Latka logo
Cure51 logo

Cure51revenue

Paris, FranceFounded 2021CEO Nicolas Wolikow

Cure51 is a Paris-based Techbio company on a mission to decode the biology of exceptional cancer patients - the Outliers - who survive aggressive cancers against all odds.

cure51.comLinkedInUpdated Sep 10, 2026
Annual revenue
$9.5M
Sep 2025EST
Employees
52
Sep 2025

Cure51 revenue

Cure51 has not published its revenue. Growjo puts it at about $9.5M a year (September 2025).

$0
$2.5M
$5M
$7.5M
$0
–
$9.5M
20212022–242025
ReportedEstimateFounded 2021 at $0; every reading has its own bar
As ofRevenueSource
Sep 2025$9.5MESTGrowjo estimate

Cure51 CEO & employees

Nicolas Wolikow is CEO of Cure51. Cure51 has 52 employees (September 2025, LinkedIn).

0
20
40
52
2025
ReportedOne figure per year; a reported figure wins over an estimate

Cure51 FAQ

What is Cure51's revenue?

Growjo estimates Cure51's revenue at about $9.5M a year (September 2025). The company hasn't published its own figure.

How many employees does Cure51 have?

Cure51 has 52 employees as of September 2025, according to LinkedIn.

Who is the CEO of Cure51?

Nicolas Wolikow is the CEO of Cure51.

Categories

Companies in

How this page is sourced

1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Cure51? Join the podcast